Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects

计划入组 46 人 · 首次发布于 2015 年 4 月 24 日

Reliability and Validity Evaluation of the BePoW Device

计划入组 60 人 · 首次发布于 2024 年 2 月 2 日

PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg

计划入组 26 人 · 首次发布于 2013 年 7 月 12 日

BEPO albumin

peptide therapeutic (BEPO, pain) (MedinCell)

prozac-like peptide therapeutic (BEPO) (MedinCell)

Depo NF Sub, LLC

United States

Teva and MedinCell's Long-Acting Risperidone Injection Expands Global Reach with Canadian Approval

Medincell Raises Capital to Advance Long-Acting Injectable Platform and Expand Partnerships

Medincell Appoints Edna Venneker, MD, as Chief Medical Officer